Strata Critical Medical (NASDAQ:SRTA) CAO Sells $239,798.25 in Stock

Strata Critical Medical (NASDAQ:SRTA) CAO Amir Cohen sold 40,575 shares of Strata Critical Medical stock in a transaction that occurred on Friday, May 22nd. The shares were sold at an average price of $5.91, for a total transaction of $239,798.25. Following the completion of the transaction, the chief accounting officer directly owned 151,263 shares in the company, valued at $893,964.33. This trade represents a 21.15% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Amir Cohen also recently made the following trade(s):

• On Thursday, May 21st, Amir Cohen sold 10,300 shares of Strata Critical Medical stock. The shares were sold at an average price of $5.79, for a total transaction of $59,637.00.

Strata Critical Medical Price Performance

Shares of NASDAQ:SRTA opened at $6.47 on Friday. The company has a 50 day moving average price of $4.92. The company has a market capitalization of $559.85 million, a PE ratio of -80.88 and a beta of 2.15. Strata Critical Medical has a 1 year low of $3.40 and a 1 year high of $6.50.

Strata Critical Medical (NASDAQ:SRTA) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.07. The business had revenue of $67.38 million for the quarter. Strata Critical Medical had a net margin of 20.56% and a negative return on equity of 4.06%. As a group, sell-side analysts predict that Strata Critical Medical will post -0.14 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of SRTA. Seelaus Asset Management LLC lifted its stake in shares of Strata Critical Medical by 32.7% in the 1st quarter. Seelaus Asset Management LLC now owns 24,350 shares of the company’s stock valued at $102,000 after acquiring an additional 6,000 shares during the last quarter. Granite Investment Partners LLC lifted its stake in shares of Strata Critical Medical by 77.0% in the 1st quarter. Granite Investment Partners LLC now owns 18,181 shares of the company’s stock valued at $76,000 after acquiring an additional 7,911 shares during the last quarter. Principal Financial Group Inc. bought a new position in shares of Strata Critical Medical in the 1st quarter valued at $537,000. Dimensional Fund Advisors LP lifted its stake in shares of Strata Critical Medical by 11.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,617,104 shares of the company’s stock valued at $6,759,000 after acquiring an additional 172,154 shares during the last quarter. Finally, Quantinno Capital Management LP lifted its stake in shares of Strata Critical Medical by 98.7% in the 1st quarter. Quantinno Capital Management LP now owns 143,239 shares of the company’s stock valued at $599,000 after acquiring an additional 71,155 shares during the last quarter. 47.36% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

SRTA has been the topic of a number of recent analyst reports. B. Riley Financial initiated coverage on shares of Strata Critical Medical in a research note on Wednesday, March 25th. They issued a “buy” rating and a $8.00 price objective on the stock. Weiss Ratings raised shares of Strata Critical Medical from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, May 11th. Craig Hallum initiated coverage on shares of Strata Critical Medical in a research note on Wednesday, March 25th. They issued a “buy” rating and a $8.00 price objective on the stock. Finally, Zacks Research upgraded shares of Strata Critical Medical to a “hold” rating in a research report on Thursday, March 26th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $8.00.

Strata Critical Medical Company Profile

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.